Skip to main content
Watch Insiders

Corporate insider profile

Abraham Ceesay Insider Trades

Latest reported as Chief Executive Officer of Rapport Therapeutics, Inc. (RAPP).

Purchase filings
0
Reported companies
1
Net open-market value
-$4,788,815.35
Latest transaction
Oct 21, 2026

Affiliated corporations

Reported company relationships

RAPPLatest reported

Rapport Therapeutics, Inc.

Chief Executive Officer

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Oct 21, 2026Rapport Therapeutics, Inc. (RAPP)Chief Executive OfficerSale2,210$29.16$64,448
Oct 7, 2026Rapport Therapeutics, Inc. (RAPP)Chief Executive OfficerSale4,522$31.68$143,273
Sep 23, 2026Rapport Therapeutics, Inc. (RAPP)Chief Executive OfficerSale2,210$39.17$86,565
Sep 8, 2026Rapport Therapeutics, Inc. (RAPP)Chief Executive OfficerSale8,210$45.61$374,498
Aug 25, 2026Rapport Therapeutics, Inc. (RAPP)Chief Executive OfficerSale18,921$49.57$937,957
Aug 11, 2026Rapport Therapeutics, Inc. (RAPP)Chief Executive OfficerSale51,499$47.25$2,433,178
Jul 27, 2026Rapport Therapeutics, Inc. (RAPP)Chief Executive OfficerSale2,210$42.11$93,061
Jul 14, 2026Rapport Therapeutics, Inc. (RAPP)Chief Executive OfficerSale8,210$40.00$328,437
Jun 29, 2026Rapport Therapeutics, Inc. (RAPP)Chief Executive OfficerSale8,220$39.83$327,398